D016756

4 trials

Sponsors

Watarai Yoshihiko, Miyahara Nobuaki, Sato Toshiyuki, Deguchi Masashi

Conditions

Antibody-mediated rejection after kidney transplantation Antibody mediated rejectionMyotonic Dystrophy Type 1(DM1) Myotonic dystrophy, myotonic dystrophy type 1, DM1, muscular dystrophy, muscle disease, muscle weakness, myotonia, muscle stiffness, difficulty relaxing muscles, hand grip problems, facial weakness, difficulty walking, genetic disorder, inherited disease, neuromuscular disease, nervous system disorder, progressive disease, Steinert disease, muscle atrophy, fatigue, daily activity limitations, swallowing difficulty, respiratory muscle weakness, cardiac involvement,Primary recurrent pregnancy loss with unknown risk factors Habitual Abortions, Recurrent Abortion, Recurrent Miscarriage, Recurrent Early Pregnancy Lossidiopathic pulmonary fibrosis

Phase 2

Intravenous Immunoglobulin for Acute Exacerbation of Idiopathic Pulmonary Fibrosis

RecruitingJPRN-jRCT1061220010

Miyahara Nobuakiidiopathic pulmonary fibrosis

Start: 2022-08-17Target: 24Updated: 2026-06-29

Phase 3

Efficacy, Safety, and Tolerability of DYNE-101 in Participants with Myotonic Dystrophy Type 1

RecruitingJPRN-jRCT2051260017

Sato ToshiyukiMyotonic Dystrophy Type 1(DM1) Myotonic dystrophy, myotonic dystrophy type 1, DM1, muscular dystrophy, muscle disease, muscle weakness, myotonia, muscle stiffness, difficulty relaxing muscles, hand grip problems, facial weakness, difficulty walking, genetic disorder, inherited disease, neuromuscular disease, nervous system disorder, progressive disease, Steinert disease, muscle atrophy, fatigue, daily activity limitations, swallowing difficulty, respiratory muscle weakness, cardiac involvement,

Start: 2026-04-10Target: 12Updated: 2026-05-25

Unknown Phase

A validation study to evaluate the efficacy of immunoglobulin therapy for the patients with recurrent pregnancy loss who do not have any history of live births and risk factors for recurrent pregnancy loss.

Active, not recruitingJPRN-jRCTs051220193

Deguchi MasashiPrimary recurrent pregnancy loss with unknown risk factors Habitual Abortions, Recurrent Abortion, Recurrent Miscarriage, Recurrent Early Pregnancy Loss

Start: 2023-03-15Target: 40Updated: 2026-06-29

Treatment of antibody-mediated rejection

RecruitingJPRN-jRCT1041240202

Watarai YoshihikoAntibody-mediated rejection after kidney transplantation Antibody mediated rejection

Start: 2025-03-13Target: 50Updated: 2026-06-29

Related Papers

Intravenous immunoglobulin for acute exacerbation of fibrotic idiopathic interstitial pneumonias.

PubMed2022-12-194 citations